Optimum Investment Advisors increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 3,186 shares of the financial services provider’s stock after purchasing an additional 162 shares during the period. Optimum Investment Advisors’ holdings in iShares Biotechnology ETF were worth $464,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Good Life Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 59.4% during the third quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock worth $388,000 after acquiring an additional 993 shares during the period. SPC Financial Inc. boosted its holdings in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares during the period. SeaCrest Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 203.7% during the third quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock worth $1,487,000 after acquiring an additional 6,850 shares during the period. Prism Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $206,000. Finally, Magnus Financial Group LLC boosted its holdings in shares of iShares Biotechnology ETF by 19.9% during the third quarter. Magnus Financial Group LLC now owns 12,863 shares of the financial services provider’s stock worth $1,873,000 after acquiring an additional 2,137 shares during the period. Institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Trading Down 0.5 %
NASDAQ IBB opened at $145.69 on Friday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57. The company has a 50 day moving average of $145.57 and a 200-day moving average of $139.59.
iShares Biotechnology ETF Dividend Announcement
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading
- Five stocks we like better than iShares Biotechnology ETF
- What is a Low P/E Ratio and What Does it Tell Investors?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- How is Compound Interest Calculated?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
